203 related articles for article (PubMed ID: 37304815)
1. Measurement of changes in uterine and fibroid volume during treatment of heavy menstrual bleeding (HMB).
Yin K; Whitaker L; Hojo E; McLenachan S; Walker J; McKillop G; Stubbs C; Priest L; Cruz M; Roberts N; Critchley H
Hum Reprod Open; 2023; 2023(3):hoad021. PubMed ID: 37304815
[TBL] [Abstract][Full Text] [Related]
2. Safety and efficacy of the selective progesterone receptor modulator asoprisnil for heavy menstrual bleeding with uterine fibroids: pooled analysis of two 12-month, placebo-controlled, randomized trials.
Stewart EA; Diamond MP; Williams ARW; Carr BR; Myers ER; Feldman RA; Elger W; Mattia-Goldberg C; Schwefel BM; Chwalisz K
Hum Reprod; 2019 Apr; 34(4):623-634. PubMed ID: 30865281
[TBL] [Abstract][Full Text] [Related]
3. Selective progesterone receptor modulator (SPRM) ulipristal acetate (UPA) and its effects on the human endometrium.
Whitaker LH; Murray AA; Matthews R; Shaw G; Williams AR; Saunders PT; Critchley HO
Hum Reprod; 2017 Mar; 32(3):531-543. PubMed ID: 28130434
[TBL] [Abstract][Full Text] [Related]
4. Individualized vaginal bleeding experience of women with uterine fibroids in the PEARL I randomized controlled trial comparing the effects of ulipristal acetate or placebo.
Barlow DH; Lumsden MA; Fauser BC; Terrill P; Bestel E
Hum Reprod; 2014 Mar; 29(3):480-9. PubMed ID: 24457604
[TBL] [Abstract][Full Text] [Related]
5. A 12-month extension study to evaluate the safety and efficacy of asoprisnil in women with heavy menstrual bleeding and uterine fibroids.
Diamond MP; Stewart EA; Williams ARW; Carr BR; Myers ER; Feldman RA; Elger W; Mattia-Goldberg C; Schwefel BM; Chwalisz K
Hum Reprod Open; 2019; 2019(4):hoz027. PubMed ID: 31777761
[TBL] [Abstract][Full Text] [Related]
6. Markers of human endometrial hypoxia can be detected in vivo and ex vivo during physiological menstruation.
Reavey JJ; Walker C; Nicol M; Murray AA; Critchley HOD; Kershaw LE; Maybin JA
Hum Reprod; 2021 Mar; 36(4):941-950. PubMed ID: 33496337
[TBL] [Abstract][Full Text] [Related]
7. Selective progesterone receptor modulators (SPRMs) for uterine fibroids.
Murji A; Whitaker L; Chow TL; Sobel ML
Cochrane Database Syst Rev; 2017 Apr; 4(4):CD010770. PubMed ID: 28444736
[TBL] [Abstract][Full Text] [Related]
8. ESHRE guideline: endometriosis.
Becker CM; Bokor A; Heikinheimo O; Horne A; Jansen F; Kiesel L; King K; Kvaskoff M; Nap A; Petersen K; Saridogan E; Tomassetti C; van Hanegem N; Vulliemoz N; Vermeulen N;
Hum Reprod Open; 2022; 2022(2):hoac009. PubMed ID: 35350465
[TBL] [Abstract][Full Text] [Related]
9. Pharmacodynamics and safety of the novel selective progesterone receptor modulator vilaprisan: a double-blind, randomized, placebo-controlled phase 1 trial in healthy women.
Schütt B; Kaiser A; Schultze-Mosgau MH; Seitz C; Bell D; Koch M; Rohde B
Hum Reprod; 2016 Aug; 31(8):1703-12. PubMed ID: 27288475
[TBL] [Abstract][Full Text] [Related]
10. [Selective progesterone receptor modulator (ulipristal acetate--a new option in the pharmacological treatment of uterine fibroids in women].
Szamatowicz M; Kotarski J
Ginekol Pol; 2013 Mar; 84(3):219-22. PubMed ID: 23700851
[TBL] [Abstract][Full Text] [Related]
11. Two-year efficacy and safety of relugolix combination therapy in women with endometriosis-associated pain: SPIRIT open-label extension study.
Becker CM; Johnson NP; As-Sanie S; Arjona Ferreira JC; Abrao MS; Wilk K; Imm SJ; Mathur V; Perry JS; Wagman RB; Giudice LC
Hum Reprod; 2024 Mar; 39(3):526-537. PubMed ID: 38243752
[TBL] [Abstract][Full Text] [Related]
12. Ulipristal acetate for uterine fibroids: 2 years of real world experience in a UK hospital.
Woodhead N; Pounds R; Irani S; Pradhan P
J Obstet Gynaecol; 2018 Aug; 38(6):813-817. PubMed ID: 29526144
[TBL] [Abstract][Full Text] [Related]
13. Top 10 priorities for future infertility research: an international consensus development study† ‡.
Duffy JMN; Adamson GD; Benson E; Bhattacharya S; Bhattacharya S; Bofill M; Brian K; Collura B; Curtis C; Evers JLH; Farquharson RG; Fincham A; Franik S; Giudice LC; Glanville E; Hickey M; Horne AW; Hull ML; Johnson NP; Jordan V; Khalaf Y; Knijnenburg JML; Legro RS; Lensen S; MacKenzie J; Mavrelos D; Mol BW; Morbeck DE; Nagels H; Ng EHY; Niederberger C; Otter AS; Puscasiu L; Rautakallio-Hokkanen S; Sadler L; Sarris I; Showell M; Stewart J; Strandell A; Strawbridge C; Vail A; van Wely M; Vercoe M; Vuong NL; Wang AY; Wang R; Wilkinson J; Wong K; Wong TY; Farquhar CM; ; AlAhwany H; Balaban O; Barton F; Beebeejaun Y; Boivin J; Bosteels JJA; Calhaz-Jorge C; D’Angelo A; F. Dann L; J. De Jonge C; du Mez E; A. Ferriani R; Gerval MO; J. Gingel L; Greenblatt EM; Hartshorne G; Helliwell C; Hughes LJ; Jo J; Jovanović J; Kiesel L; Kietpeerakool C; Kostova E; Kucuk T; Kumar R; Lawrence RL; Lee N; Lindemann KE; Loto OM; Lutjen PJ; MacKinven M; Mascarenhas M; McLaughlin H; Mourad SM; Nguyen LK; Norman RJ; Olic M; Overfield KL; Parker-Harris M; Repping S; Rizzo R; Salacone P; Saunders CH; Sengupta R; Sfontouris IA; Silverman NR; Torrance HL; Uphoff EP; Wakeman SA; Wischmann T; Woodward BJ; Youssef MA
Hum Reprod; 2020 Dec; 35(12):2715-2724. PubMed ID: 33252677
[TBL] [Abstract][Full Text] [Related]
14. Preoperative medical therapy before surgery for uterine fibroids.
Lethaby A; Puscasiu L; Vollenhoven B
Cochrane Database Syst Rev; 2017 Nov; 11(11):CD000547. PubMed ID: 29139105
[TBL] [Abstract][Full Text] [Related]
15. The management of uterine leiomyomas.
Vilos GA; Allaire C; Laberge PY; Leyland N;
J Obstet Gynaecol Can; 2015 Feb; 37(2):157-178. PubMed ID: 25767949
[TBL] [Abstract][Full Text] [Related]
16. Elective freezing of embryos versus fresh embryo transfer in IVF: a multicentre randomized controlled trial in the UK (E-Freeze).
Maheshwari A; Bell JL; Bhide P; Brison D; Child T; Chong HY; Cheong Y; Cole C; Coomarasamy A; Cutting R; Hardy P; Hamoda H; Juszczak E; Khalaf Y; Kurinczuk JJ; Lavery S; Linsell L; Macklon N; Mathur R; Pundir J; Raine-Fenning N; Rajkohwa M; Scotland G; Stanbury K; Troup S; Bhattacharya S
Hum Reprod; 2022 Mar; 37(3):476-487. PubMed ID: 34999830
[TBL] [Abstract][Full Text] [Related]
17. Influence of ulipristal acetate therapy compared with uterine artery embolization on fibroid volume and vascularity indices assessed by three-dimensional ultrasound: prospective observational study.
Czuczwar P; Wozniak S; Szkodziak P; Milart P; Wozniakowska E; Wrona W; Paszkowski T
Ultrasound Obstet Gynecol; 2015 Jun; 45(6):744-50. PubMed ID: 25251811
[TBL] [Abstract][Full Text] [Related]
18. Top 10 priorities for future infertility research: an international consensus development study.
Duffy JMN; Adamson GD; Benson E; Bhattacharya S; Bhattacharya S; Bofill M; Brian K; Collura B; Curtis C; Evers JLH; Farquharson RG; Fincham A; Franik S; Giudice LC; Glanville E; Hickey M; Horne AW; Hull ML; Johnson NP; Jordan V; Khalaf Y; Knijnenburg JML; Legro RS; Lensen S; MacKenzie J; Mavrelos D; Mol BW; Morbeck DE; Nagels H; Ng EHY; Niederberger C; Otter AS; Puscasiu L; Rautakallio-Hokkanen S; Sadler L; Sarris I; Showell M; Stewart J; Strandell A; Strawbridge C; Vail A; van Wely M; Vercoe M; Vuong NL; Wang AY; Wang R; Wilkinson J; Wong K; Wong TY; Farquhar CM;
Fertil Steril; 2021 Jan; 115(1):180-190. PubMed ID: 33272617
[TBL] [Abstract][Full Text] [Related]
19. Predictive factor for volume reduction of uterine fibroids after short-term use of ulipristal acetate.
Yun BS; Seong SJ; Jung YW; Kim ML; Bae HS; Kim MK; Shim SS
Eur J Obstet Gynecol Reprod Biol; 2018 May; 224():133-136. PubMed ID: 29602142
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
